Update in pediatric anaphylaxis: a systematic review.
Clinical Pediatrics · 2013-02-07 · Systematic review
Abstract
Anaphylaxis is common in children and has many differences across age groups. A systematic review of the literature from the past 5 years was conducted with the goal of updating the pediatrician. Food is the most common trigger in children, but insect venom and drugs are other typical causes. Clinical diagnostic criteria include dermatological, respiratory, cardiovascular, and gastrointestinal manifestations. A biphasic reaction is seen in some, with recurrence usually within 8 hours of the initial episode. Epinephrine is the drug of choice for acute reactions and the only medication shown to be lifesaving when administered promptly, but it is underutilized. Patients should have ready access to ≥2 doses of an epinephrine autoinjector, with thorough training regarding correct use of a given device and an emergency action plan. Management of anaphylaxis in schools presents distinct challenges. Pediatricians are in a unique position to assess and treat these patients chronically.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Cardiovascular drugs · Adrenaline · Children
Related articles
- Pearls for practice from the 2023 joint task force anaphylaxis practice parameter. (Curr Opin Pediatr, 2025)
- Guideline review: Epinephrine use in anaphylaxis (AAP guideline 2017). (Arch Dis Child Educ Pract Ed, 2020)
- Epinephrine for First-aid Management of Anaphylaxis. (Pediatrics, 2017)
- ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2012 update. (J Paediatr Child Health, 2013)
- The RCPCH care pathway for children at risk of anaphylaxis: an evidence and consensus based national approach to caring for children with life-threatening allergies. (Arch Dis Child, 2011)
- AB127. Unequal Access, unequal outcomes: disparities in availability and accessibility to self-injectable adrenaline for pediatric anaphylaxis in Asia-Pacific (Journal of Public Health and Emergency, 2026)